Using the value of 0.24 fmoles/μg DNA as breaking point between high and low binding capacities, we quantified receptors for 17β-estradiol (ER), 5α-dihydrotestosterone (DHTR), progesterone (PR) and cortisol (CR) in normal and neoplastic human uterine tissues. Concerning receptors occurrence, significant relationships were observed between ER and PR, ER and DHTR, and DHTR and PR. A direct correlation between the presence of ER and tumor grading was found: PR was less frequent in grade II and absent in grade III endometrial carcinoma, however this was not a significant correlation. In endometrial carcinoma at least 1 of the receptors was detected in 67-91% of the cases, 3 receptors (ER, DHTR, PR) in 56%, and all 4 receptors in 45%. The simultaneous detection of multiple receptors could play an important role in determining hormone response.
Get full access to this article
View all access options for this article.
References
1.
AsselinJ., LabrieF., GourdeauY., BonneC., RaynaudJ.P.: Binding of (3H) methyltrienolone (R 1881) in rat prostate and human benign prostatic hypertrophy (BPH).Steroids,28: 449–459, 1976.
2.
BonteJ.: Medroxyprogesterone in the management of primary and recurrent or metastatic uterine adenocarcinoma.Acta Obstet. Gynecol. Scand.,19: 21–24, 1972.
3.
DaxenbichlerG., GrillH.J., WittliffJ.L., DapuntO.: Comparison of specific estrogen and progesterone binding proteins in human myometrium and leiomyomas.Acta Endocrinol.,84: 62–63, 1977.
4.
EvansL.H., MartinJ.D., HähnelR.: Estrogen receptor concentration in normal and pathological human uterine tissues.J. Clin. Endocrinol. Metab.,38: 23–32, 1973.
5.
FazekasA.G., MacfarlaneJ.K.: Macromolecular binding of glucocorticoids in human mammary carcinoma.Cancer Res.,37: 640–645, 1977.
6.
GrilliS., FerreriA.M., GolaG., RocchettaR., OrlandiC., ProdiG.: Cytoplasmic receptors for 17β-estradiol, 5α- normal and abnormal human uterine tissues.Cancer Lett.,2: 247–258, 1977.
7.
GueriguianJ.L., SawyerM.E., PearlmanW.H.: A comparative study of progesterone- and cortisol-binding activity in the uterus and serum of pregnant and nonpregnant women.J. Endocrinol.,61: 331–345, 1974.
8.
HorwitzK.B., McGuireW.L., PearsonO.H., SegaloffA.: Predictive response to endocrine therapy in human breast cancer: an hypothesis.Science,189: 726–727, 1975.
9.
LippmanM., BolanG., HuffK.: The effect of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture.Cancer Res.,36: 4602–4609, 1976.
10.
LippmanM., BolanG., HuffK.: The effect of androgens and antiandrogens on hormone-responsive human cancer in long-term tissue culture.Cancer Res.,36: 4610–4618, 1976.
11.
LiskowskiL., RoseD.P., DondlingerP., OlenickJ.S.: The determination of progesterone receptors in breast cancer and their relationship to estrogen receptors.Clin. Chim. Acta,71: 309–318, 1976.
12.
McGuireW.L., PearsonO.H., SegaloffA.: Predicting hormone responsiveness in human breast cancer. pp. 17–30. In: Estrogen Receptors in Human Breast Cancer.McGuireW.L., CarboneP.P., VollmerE.P. (eds.). Raven Press, New York, 1975.
13.
PhilibertD., RaynaudJ.P.: Progesterone binding in the immature rabbit and guinea pig uterus.Endocrinology,94: 627–632, 1974.
14.
PichonM.F., MilgromE.: Characterization and assay of progesterone receptor in human mammary carcinoma.Cancer Res.,37: 464–471, 1977.
15.
PollowK., LübbertH., BoquoiE., KreuzerE., PollowD.: Characterization and comparison of receptor for 17β-estradiol and progesterone in human proliferative endometrium and endometrial carcinoma.Endocrinology,96: 319–328, 1975.
16.
PollowK., BoquoiE.: Effect of gestagen therapy upon estradiol- and progesterone-receptor-level and 17β-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma.Z. Krebsforsch.,86: 231–242, 1976.
17.
RaoB.R., WiestW.G., AllenW.H.: Progesterone « receptor » in human endometrium.Endocrinology,95: 1275–1281, 1971.
18.
RosenF., KaiserN., MayerM., MilhollandR.J.: Glucocorticoids: receptors and mechanism of action in lymphoid tissue and muscle.Methods Cancer Res.,13: 67–100, 1976.
19.
RousseauG.G., BaxterJ.D., TomkinsG.M.: Glucocorticoid receptors: relation between steroid binding and biological effects.J. Mol. Biol,67: 99–115, 1972.
20.
ScatchardG.: The attraction of proteins for small molecules and ions. Ann. N.Y.Acad. Sci.,51: 660–672, 1949.
21.
TereniusL.: Estrogen and progesterone binders in human and rat mammary carcinoma.Eur. J. Cancer,9: 291–294, 1973.
22.
TramsG., EngelB., LehmannF., MaassH.: Specific binding of oestradiol in human uterine tissue.Acta Endocrinol.,72: 351–360, 1973.
23.
VermaU., LaumasK.R.: In vitro binding of progesterone to receptors in the human endometrium and the myometrium.Biochim. Biophys. Acta,317: 403–419, 1973.
24.
WittliffJ.L.: Steroid-binding proteins in normal and neoplastic mammary cells.Methods Cancer Res.,11: 293–354, 1975.
25.
YoungP.C.M., ClearyR.E.: Characterization and properties of progesterone-binding components in human endometrium.J. Clin. Endocrinol. Metab.,39: 425–439, 1974.
26.
YoungP.C.M., ErlichC.E., ClearyR.E.: Progesterone binding in human endometrial carcinomas.Am. J. Obstet. Gynecol.,125: 353–360, 1976.
